1-2 of 2
duration of treatment
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Measurable residual disease in elderly acute myeloid leukemia: results from the PETHEMA-FLUGAZA phase 3 clinical trial

Clinical Trials & Observations
Catia Simoes, Bruno Paiva, David Martínez-Cuadrón, Juan-Miguel Bergua, Susana Vives, Lorenzo Algarra, Mar Tormo, Pilar Martinez, Josefina Serrano, Pilar Herrera, Fernando Ramos, Olga Salamero, Esperanza Lavilla, Cristina Gil, Jose-Luis Lopez, Maria-Belen Vidriales, Jorge Labrador, Jose-Francisco Falantes, María-José Sayas, Rosa Ayala, Joaquin Martinez-Lopez, Sara Villar, Maria-Jose Calasanz, Felipe Prosper, Jesús F. San-Miguel, Miguel Ángel Sanz, Pau Montesinos
Journal: Blood Advances
Blood Adv (2021) 5 (3): 760–770.
https://doi.org/10.1182/bloodadvances.2020003195
Published: 2021
Includes: Supplemental data
Journal Articles

Comparing low-molecular-weight heparin dosing for treatment of venous thromboembolism in patients with obesity (RIETE registry)

Clinical Trials & Observations
Reza Mirza, Robby Nieuwlaat, Juan J. López-Núñez, Raquel Barba, Arnav Agarwal, Carme Font, Maurizio Ciammaichella, Elvira Grandone, Rick Ikesaka, Mark Crowther, Manuel Monreal, the RIETE Investigators
Journal: Blood Advances
Blood Adv (2020) 4 (11): 2460–2467.
https://doi.org/10.1182/bloodadvances.2019001373
Published: 2020
Includes: Supplemental data